Filters
Study Phase
Recruitment Status
Study Type
Eligibility Sex
Healthy Volunteers
Found 539299 clinical trials
Sort by:
Impact of Lung Boost Device on Ventilatory Functions and Fatigue in Patients With Interstitial Lung Diseases
Not Applicable
Not yet recruiting
- Conditions
- Interstitial Lung Disease
- Interventions
- Device: Lung Boost Device TrainingOther: Traditional physical therapy programDrug: Medical Treatment
- First Posted Date
- 2025-05-26
- Last Posted Date
- 2025-05-26
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 40
- Registration Number
- NCT06991153
- Locations
- 🇪🇬
Faculty of physical therapy, Cairo University, Giza, Egypt
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Phase 3
Recruiting
- Conditions
- Endometrial Cancer
- Interventions
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 600
- Registration Number
- NCT06989112
- Locations
- 🇬🇧
Research Site, Northwood, United Kingdom
Outpatient Care Pathway for Patients Treated Intra-arterially for Primary Liver Cancer
Not Applicable
Not yet recruiting
- Conditions
- Hepato Cellular Carcinoma (HCC)
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- University Hospital, Angers
- Target Recruit Count
- 206
- Registration Number
- NCT06990659
- Locations
- 🇫🇷
University hospital of Amiens, Amiens, France
🇫🇷University hospital of Angers, Angers, France
🇫🇷University hospital of Besançon, Besançon, France
Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers
Not Applicable
Not yet recruiting
- Conditions
- Sleep DisorderAging
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 80
- Registration Number
- NCT06990256
- Locations
- 🇨🇳
Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Phase 1
Not yet recruiting
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Celgene
- Target Recruit Count
- 62
- Registration Number
- NCT06988488
- Locations
- 🇺🇸
Local Institution - 0001, Birmingham, Alabama, United States
🇺🇸Local Institution - 0029, New Haven, Connecticut, United States
🇺🇸Local Institution - 0028, Hackensack, New Jersey, United States
A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults
Phase 1
Recruiting
- Conditions
- Chronic Hepatitis b
- Interventions
- Biological: AVX70371Other: Placebo
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- AstriVax Therapeutics
- Target Recruit Count
- 16
- Registration Number
- NCT06989788
- Locations
- 🇧🇪
University Hospital Ghent - Centrum voor Vaccinologie (CEVAC), Ghent, Belgium
Examining the Most Effective Method to Reduce Running Ground Contact Time
Not Applicable
Active, not recruiting
- Conditions
- Healthy Runners
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Keller Army Community Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06988709
- Locations
- 🇺🇸
Keller Army Community Hospital, West Point, New York, United States
Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization
Phase 2
Not yet recruiting
- Conditions
- SalidrosideRandomized Controlled TrialIn Vitro FertilizationAssisted Reproductive Technology
- Interventions
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- The Second Hospital of Shandong University
- Target Recruit Count
- 370
- Registration Number
- NCT06990685
- Locations
- 🇨🇳
The Second Hospital of Shandong University,, Jinan, Shandong, China
Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health
Not yet recruiting
- Conditions
- EndometriosisInfertilityEndometrial CancerAdenomyosis, Endometriosis
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Cycle Therapeutics Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT06990971
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
Phase 3
Recruiting
- Conditions
- Type 2 Diabets MellitusCognitive Ability, General
- Interventions
- Drug: Cilostazol / Ginko Leaf Dried Ext.Drug: Placebo
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06989697
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath